ATEA ASA ORD overview

STOCKHOLM, SE / ACCESSWIRE / November 23, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") announces that the agreement with the Västra Götaland Region (VGR) for the delivery of Dosell medication dispensers has now been concluded. This follows the earlier communication of the award decision and covers 1,800 units, with a maximum of 2,250. The agreement is owned by Atea Sweden AB. This new agreement, extending until 2025 with the possibility of an extension until 2027,...

STOCKHOLM, SWEDEN / ACCESSWIRE / October 12, 2023 / iZafe Group (STO:IZAFE-B) iZafe Group AB ("iZafe Group") announces that, in partnership with Atea Sverige AB, they have been awarded a contract with Västra Götalandsregionen for the provision of iZafe's medication dispensers, Dosell. The contract covers 1,800 units, up to a maximum of 2,250 units, with an estimated value of 42-52 MSEK. The agreement is held by Atea Sverige AB. The contract term is for two years, with the possibility of a...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atea Pharmaceuticals, Inc. - AVIR PR Newswire NEW YORK, Jan. 27, 2022 NEW YORK , Jan. 27, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Atea Pharmaceuticals, Inc. ("Atea" or the "Company") (NASDAQ: AVIR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Atea and certain of its...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atea Pharmaceuticals, Inc. - AVIR PR Newswire NEW YORK, Jan. 17, 2022 NEW YORK , Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Atea Pharmaceuticals, Inc. ("Atea" or the "Company") (NASDAQ: AVIR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Atea and certain of its...

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atea Pharmaceuticals, Inc. (“Atea” or the “Company”) (NASDAQ: AVIR). Investors who purchased Atea shares are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/avir . The investigation concerns whether Atea and certain of its officers and/or directors have violated federal securities laws. On October 19,...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atea Pharmaceuticals, Inc. - AVIR PR Newswire NEW YORK, Jan. 7, 2022 NEW YORK , Jan. 7, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Atea Pharmaceuticals, Inc. ("Atea" or the "Company") (NASDAQ: AVIR). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Atea and certain of its...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Astea International (OTC: ATEA) to IFS Americas, Inc. Under the terms of the proposed transaction, shareholders of Astea will receive only $12.00 in cash for each share of Astea that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the...

Malmo, Sweden, January 19, 2018 - Hoylu, a leading enterprise collaboration company, announced today that it has entered into a reseller partnership agreement with Atea Norway, a leading IT infrastructure integrator for businesses and public-sector organizations in Europe. This agreement expands Hoylu's partnership with Atea, which was first announced earlier this year with Atea Sweden. The two companies will work together to provide Hoylu's products and services for collaboration and ideation...